News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cerulean Pharma Inc. Appoints Chief Medical Officer, Edward Garmey, M.D.


5/17/2011 9:42:03 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cerulean Pharma Inc., a leader in designing and developing tumor-targeted nanopharmaceuticals, today announced the appointment of Edward Garmey, M.D., to serve as Chief Medical Officer and Senior Vice President. Dr. Garmey will succeed Dr. John Ryan, who has been named Chairman of the Company’s Medical Advisory Board.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES